SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
947GHENT, Belgium, 5 October 2009 - Ablynx [Euronext Brussels: ABLX], announced todnigel bates-10/5/2009
946Ghent, Belgium, 30 September 2009 – Ablynx [Euronext Brussels: ABLX], today annonigel bates-10/5/2009
945GHENT, Belgium, 1 September 2009 - Ablynx [Euronext Brussels: ABLX] today announnigel bates-9/9/2009
944MorphoSys Announces Clinical Milestone in Cancer Program with Bayer Schering PhaGermanecki-9/8/2009
943CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX - News) announced todnigel bates-8/26/2009
942GHENT, Belgium, 18 August 2009 - Ablynx [Euronext Brussels: ABLX] today announcenigel bates-8/26/2009
941UPDATE 2-Genmab slumps as Glaxo-partnered drug hits setback Tue Aug 18, 2009 5:5A.J. Mullen-8/19/2009
940Genmab Announces Preliminary Top-Line Results for Arzerra(TM) in Front Line CLL A.J. Mullen-8/11/2009
939>>Is it possible to evalute the source of CNTO 1959<< Don't knonigel bates-8/4/2009
938I'm not used how to trade with the ADRs, because I have a German broker. ThGermanecki-8/3/2009
937Morphosys has a US adr I believe. But it seems almost never traded. How does onesaagua-7/30/2009
936UPDATE 1-Glaxo, Genmab drug meets goal in arthritis study Wed Jul 29, 2009 5:18pA.J. Mullen-7/29/2009
935MorphoSys AG Reports Six Months 2009 Results 07/29/2009 at 07:00 AM Pipeline EGermanecki-7/29/2009
934Is there a website that lists all mab drugs in phase 3 testing? That would be vesaagua-7/26/2009
933IMMU, PPHM, IMGN, SGEN, CLDX, FACT, ZGEN??? Or not?saagua-7/25/2009
932GenmabIcebrg-7/23/2009
931OK, so apart from Morphosys, now that CAT, ACGX and MEDX are gone, what's lenigel bates-7/23/2009
930MorphoSys Secures Full-Term of Strategic Alliance 07/06/2009 at 07:30 AM MorpGermanecki-7/6/2009
929MorphoSys and the University of Melbourne File New Patent Applications in MOR103Germanecki-7/6/2009
928Therapeutic Antibody Program by Centocor, MorphoSys Announces Clinical MilestoneGermanecki-6/29/2009
927MorphoSys Reports Filing for Phase 1b/2a Trial for its Lead Program MOR103 in RhGermanecki-6/24/2009
926MorphoSys Strengthens Patent Position on its Core Technologies in Japan 06/18/20Germanecki-6/18/2009
925Notable that MRK is a client despite their owning GlycoFi.DewDiligence_on_SI-6/16/2009
924MorphoSys Announces Extension of Antibody Alliance with Schering-Plough 1Germanecki-6/16/2009
923Adimab Launches Novel Antibody Discovery Platform and Announces Discovery Prograscaram(o)uche-6/16/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News